 |
|
|
| |
DRUG-DRUG INTERACTIONS OF GLECAPREVIR AND PIBRENTASVIR WITH PRAVASTATIN, ROSUVASTATIN, OR DABIGATRAN ETEXILATE
|
| |
| |
Reported by Jules Levin
18th International Workshop on Clinical Pharmacology of Antiviral Therapy
Chicago, IL
June 16th, 2017
Matthew P. Kosloski, Weihan Zhao, Hong Li, Stanley Wang, Joaquin Valdes, Jens Kort, Federico Mensa, Wei Liu
1.European Medicines Agency. Pradaxa. Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/20760. Accessed, May 2017
|
| |
|
|
|
|
|
